![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2007 Karbing et al., licensee BioMed Central Ltd. Variation in the PaO2/FiO2 ratio with FiO2: mathematical and experimental description, and clinical relevance 1Center for Model-based Medical Decision Support, Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 7, E4-215, DK-9220 Aalborg East, Denmark 2Anaesthesia and Intensive Care, Region North Jutland, Aalborg Hospital, Aarhus University, DK-9000 Aalborg, Denmark 3Department of Intensive Care, Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen East, Denmark Corresponding author.Dan S Karbing: dank/at/hst.aau.dk; Søren Kjærgaard: sck/at/rn.dk; Bram W Smith: bws/at/hst.aau.dk; Kurt Espersen: kurt.espersen/at/rh.regionh.dk; Charlotte Allerød: c.allerod/at/post.tele.dk; Steen Andreassen: sa/at/hst.aau.dk; Stephen E Rees: sr/at/hst.aau.dk Received August 2, 2007; Revisions requested September 8, 2007; Revised October 2, 2007; Accepted November 7, 2007. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract Introduction Previous studies have shown through theoretical analyses that the ratio of the partial pressure of oxygen in arterial blood (PaO2) to the inspired oxygen fraction (FiO2) varies with the FiO2 level. The aim of the present study was to evaluate the relevance of this variation both theoretically and experimentally using mathematical model simulations, comparing these ratio simulations with PaO2/FiO2 ratios measured in a range of different patients. Methods The study was designed as a retrospective study using data from 36 mechanically ventilated patients and 57 spontaneously breathing patients studied on one or more occasions. Patients were classified into four disease groups (normal, mild hypoxemia, acute lung injury and acute respiratory distress syndrome) according to their PaO2/FiO2 ratio. On each occasion the patients were studied using four to eight different FiO2 values, achieving arterial oxygen saturations in the range 85–100%. At each FiO2 level, measurements were taken of ventilation, of arterial acid–base and of oxygenation status. Two mathematical models were fitted to the data: a one-parameter 'effective shunt' model, and a two-parameter shunt and ventilation/perfusion model. These models and patient data were used to investigate the variation in the PaO2/FiO2 ratio with FiO2, and to quantify how many patients changed disease classification due to variation in the PaO2/FiO2 ratio. An F test was used to assess the statistical difference between the two models' fit to the data. A confusion matrix was used to quantify the number of patients changing disease classification. Results The two-parameter model gave a statistically better fit to patient data (P < 0.005). When using this model to simulate variation in the PaO2/FiO2 ratio, disease classification changed in 30% of the patients when changing the FiO2 level. Conclusion The PaO2/FiO2 ratio depends on both the FiO2 level and the arterial oxygen saturation level. As a minimum, the FiO2 level at which the PaO2/FiO2 ratio is measured should be defined when quantifying the effects of therapeutic interventions or when specifying diagnostic criteria for acute lung injury and acute respiratory distress syndrome. Alternatively, oxygenation problems could be described using parameters describing shunt and ventilation/perfusion mismatch. Introduction The ratio of the partial pressure of oxygen in arterial blood (PaO2) to the inspired oxygen fraction (FiO2) has been used to quantify the degree of abnormalities in pulmonary gas exchange. The ratio has been used in numerous experimental studies to quantify pulmonary gas exchange before and after therapeutic intervention (for example [1-3]). The PaO2/FiO2 ratio has also been used in the clinical setting to classify patients' pulmonary gas exchange status, including the definitions of acute lung injury (ALI) (27 kPa ≤ PaO2/FiO2 < 40 kPa) and of adult respiratory distress syndrome (ARDS) (PaO2/FiO2 < 27 kPa) [4,5]. Despite its widespread use, the validity of the PaO2/FiO2 ratio as a tool for assessing pulmonary gas exchange has been questioned. Using mathematical models describing gas exchange, previous authors have simulated values of the PaO2/FiO2 ratio and have shown them to vary with the FiO2 level [6-8]. These theoretical analyses could lead us to believe that the PaO2/FiO2 ratio is a poor indicator of a patient's pulmonary gas exchange status in the clinic. This hypothesis is only true, however, if the simulations performed are indeed able to describe measured variations in the PaO2/FiO2 ratio, and if these variations happen within interesting ranges of FiO2. The latter of these conditions is crucial in determining whether this ratio is a useful scientific and clinical parameter. The ability of a particular simulation to accurately describe variation in the PaO2/FiO2 ratio depends upon the complexity of the mathematical models used. Gowda and Klocke [7] used the complex mathematical model included in the multiple inert gas elimination technique [9] to simulate changes in the PaO2/FiO2 ratio on varying FiO2 levels. This complex model has the advantage of describing pulmonary gas exchange accurately; however, its complexity means that the model is not useful for describing an individual patient in the intensive care unit. Aboab and colleagues used a simple mathematical model where an 'effective' pulmonary shunt was used to describe all ventilation/perfusion (V/Q) abnormalities in the lung [6]. This model has the advantage that values of 'effective shunt' can be estimated from clinical data. Values of 'effective shunt', however, are well known to vary with FiO2, as shown previously [10]. A single fixed value of 'effective shunt' may therefore not be able to simulate changes in the PaO2/FiO2 ratio accurately. Mathematical models have been proposed recently that describe the gas exchange using two parameters: a shunt value, and a second parameter describing the V/Q ratio [11,12]. These parameter values can be estimated simply and noninvasively in the clinic [13], and have been shown to fit data from a range of mechanically ventilated patients and spontaneously breathing patients [14-16]. These models and techniques therefore provide tools that can both describe pulmonary gas exchange in the individual patient and potentially simulate changes in the PaO2/FiO2 ratio. The purpose of the present article is to assess the relevance of variation in the PaO2/FiO2 ratio with the FiO2 level. To do so, we determined whether changes in the PaO2/FiO2 ratio can be described accurately by either the 'effective shunt' model or a two-parameter model describing shunt and V/Q mismatch. Unlike previous studies that have examined changes in the PaO2/FiO2 ratio with FiO2 theoretically through model simulation [6-8], the present analysis is performed both theoretically and experimentally by comparing model simulations with measured values of the PaO2/FiO2 ratio in a range of different patients. Simulations of the PaO2/FiO2 ratio performed with the two-parameter model are compared with those using the 'effective shunt' model to investigate whether the extra complexity of the two-parameter model is justified. The models are then used to simulate whether, and under which conditions, the PaO2/FiO2 ratio varies with FiO2, to further investigate the discrepancies between the two models and whether such variation is clinically relevant. Materials and methods Data were collected from 93 patients, most of these data being published previously [11,14,15]. Patients included postoperative surgical patients following gynaecological laparotomy [11,14] and cardiac surgery [14,15], those patients receiving intensive care therapy [14], normal subjects [14] and patients suffering from cardiac incompensation [14]. Twenty-eight of these patients were mechanically ventilated and presented in the intensive care unit; the remaining 57 patients were breathing spontaneously. Some patients were studied on more than one occasion, giving a total of 120 patient cases. In addition, new data from a further eight mechanically ventilated intensive care patients studied at one or two positive end-expiratory pressure settings were included in the analysis, adding 14 additional patient cases – giving a total of 134 patient cases. All intensive care patients had disorders in pulmonary gas exchange either due to primary infectious involvement or due to a secondary pulmonary involvement as a consequence of severe sepsis or septic shock. Ethical approval was obtained from the relevant ethics committee for all studies, and informed written and oral consent was obtained for all patients. On each occasion patients were studied using four to eight different FiO2 values, achieving arterial oxygen saturation (SaO2) values in the range 85–100%. The FiO2 values were selected on a patient-specific basis to cover this range, meaning that patients with more severe pulmonary disorders received higher FiO2 levels. Steady state was achieved at each FiO2 level either by waiting 5 minutes or by the presence of a stable end-tidal oxygen fraction over a 30-second period [13]. At steady-state conditions, measurements were taken of ventilation (FiO2, end-tidal oxygen fraction), of end-tidal carbon dioxide fraction, tidal volume, and respiratory frequency, and of arterial acid–base and oxygenation status (SaO2, PaO2, pH, partial pressure of carbon dioxide, haemoglobin, methaemoglobin, and carboxyhaemoglobin). In some patients it was necessary to administer subatmospheric oxygen fractions to achieve SaO2 in the range 85–90%, which was achieved by mixing nitrogen with air in the inspiratory gas. In 18 experiments where all patients were breathing spontaneously, arterial blood gases were only measured at two levels of FiO2. These patient cases were excluded from the current analysis, giving a total number of 116 patient cases for data analysis (51 mechanically ventilated patients, 65 spontaneously breathing patients). The PaO2/FiO2 ratio was calculated at each level of FiO2. Mathematical models The data were analysed using two mathematical models of gas exchange: the 'effective shunt' model, used by Aboab and colleagues [6]; and the two-parameter model [11,13,14], the equations of which have been published previously ([14] electronic supplement). Figure Figure11
In the 'effective shunt' model, oxygenation problems are described by a single parameter ('effective shunt') quantifying the blood flowing through the lungs without being oxygenated. In the two-parameter model, a shunt parameter is included along with the parameter fA2 describing the fraction of ventilation to a compartment receiving 90% of nonshunted perfusion. An fA2 value of 0.9 gives ideal V/Q matching, while lower fA2 values indicate V/Q mismatching. An fA2 value can be transformed into a ΔPO2 value, which describes the drop in oxygen pressure from the ventilated alveoli to the mixed blood leaving the lung capillaries; that is, the value in blood prior to the mixing of shunt. As such, ΔPO2 describes the extra oxygen pressure required at the mouth to remove an oxygenation problem due to V/Q mismatch; that is, ΔPO2 = 20 kPa means air plus 20% inspired oxygen (FiO2 = 0.41) is required. Mathematical model simulations and statistical analysis The 'effective shunt' model and the two-parameter model were used in three ways. A theoretical comparison was performed between model simulations of changes in SaO2 and the PaO2/FiO2 ratio with variation in FiO2 using the two mathematical models. To do so, simulations were performed for different values of model parameters. The models were fitted to the data from each patient in turn using the least-squares method, and the root mean square of the residuals was calculated for each of the fits. Model fits were illustrated by plotting simulated and measured values of SaO2 and the PaO2/FiO2 ratio versus FiO2. A statistical comparison of the 'goodness' of fit of the two models to the data was performed using an F test [17]. Both models were then used to analyse the variation in the PaO2/FiO2 ratio over a range of FiO2 levels. This analysis had two aims: first, to evaluate the significance of any difference between the two models when fitted to the data; and second, to investigate whether the simulated variation in the PaO2/FiO2 ratio was relevant. The relevant range was defined on an individual patient basis as the FiO2 range that resulted in a simulated value of SaO2 within the range 92–98%. The variation in the PaO2/FiO2 ratio was then used to quantify the number of patients changing disease classification as a result of varying FiO2 levels according to the two models across the defined FiO2 range, these results being presented in a confusion matrix [18]. Patients were classified into disease groups at the lowest and highest FiO2 level in the range, according to the following criteria: ARDS (PaO2/FiO2 < 27 kPa) [4,5], ALI (27 kPa ≤ PaO2/FiO2 < 40 kPa) [4,5], and normal (PaO2/FiO2 > 47 kPa) [19]. Those patients falling outside these categories are defined here as having mild hypoxemia (40 kPa ≤ PaO2/FiO2 < 47 kPa). Results Figures Figures22
Figure 2a,b Figure 3a,b Figure Figure44
The average (± standard deviation) root mean square for fitting the two-parameter model to the data was 0.5 ± 0.4%, compared with 1.4 ± 1.0% (± SD) for the 'effective shunt' model. The results of the F test showed that the two-parameter model gave a statistically better fit to the data than the 'effective shunt' model (P < 0.005). In all cases the two-parameter model fitted the data either as well as or better than the 'effective shunt' model, as described by the root mean square. In cases where the 'effective shunt' model fitted the data well (for example, Figure 4a,d The plots of FiO2 versus the PaO2/FiO2 ratio illustrated in Figure Figure44 Table 1 presents a confusion matrix showing the number of patient cases classified in the four disease groups and how this classification varied with changes in FiO2 using the two models. The left-hand column presents the number of patient cases classified in each group at a low FiO2 level. The table elements then describe the patient cases classified in each group at high FiO2. Each element can therefore be interpreted to illustrate movement between groups; for example, of the 56 patient cases classified as normal at low FiO2 level using the two-parameter model, 39 patients remain classified as normal at high FiO2 levels.
Disease classification changed in 60 of 116 patient cases (~50%) according to the 'effective shunt' model, compared with 38 of 116 patient cases (~30%) according to the two-parameter model. With an increase in the FiO2 level, but maintaining SaO2 within the range 92–98%, according to the 'effective shunt' model the number of patient cases classified as ALI and ARDS changed from 14 to 40 (~186% increase) and from 18 to 38 (~111% increase), respectively. According to the two-parameter model, the number of patient cases classified as ALI and ARDS changed from 23 to 31 (~35% increase) and from 18 to 24 (~33% increase), respectively. According to the 'effective shunt' model, disease severity only increased with FiO2 – whereas five patient cases changed classification to a less severe disease group according to the two-parameter model. Discussion The present study has investigated the variation in the PaO2/FiO2 ratio with FiO2, and the mathematical model complexity necessary to describe this variation. For the first time this analysis has been performed not only theoretically using mathematical model simulations, but also experimentally from measurements of the PaO2/FiO2 ratio taken at different FiO2 levels. The use of a two-parameter model of gas exchange to describe variation in the PaO2/FiO2 ratio has been investigated. This model has been shown, using an F test, to provide a statistically better fit to oxygenation data than an 'effective shunt' model, even when taking into account the degrees of freedom lost due to the presence of an extra parameter. This improvement in fit can be seen in the plots shown in Figure Figure4,4 In general, use of the 'effective shunt' model to simulate changes in the PaO2/FiO2 ratio results in an overestimate of the number of patient cases changing disease classification upon increasing FiO2, as illustrated in Table 1. Approximately 50% of the patient cases change classification using the 'effective shunt' model, in comparison with 30% using the two-parameter model. For five patient cases, the change in disease classification simulated by the 'effective shunt' model was in the opposite direction to that shown by the measured PaO2/FiO2 ratio – the 'effective shunt' model simulating an incorrect degree of disease severity. In these patient cases the V/Q mismatch was the major cause of hypoxemia according to the two-parameter model, and this model was necessary to simulate these changes in the PaO2/FiO2 ratio. The difference in the direction of disease classification provided by these two models can be understood by looking at Figure Figure4e.4e The necessary criteria for diagnosing ALI and ARDS include acute onset of respiratory failure, bilateral infiltrates seen on a frontal chest radiograph and no clinical evidence of left atrial hypertension in addition to the PaO2/FiO2 ratio limits [4]. In the present study, patient cases were classified only from the PaO2/FiO2 ratio. The sole difference between the criteria for ALI and ARDS, however, is the level of hypoxemia quantified by the PaO2/FiO2 ratio. Conclusion The present article has shown that the PaO2/FiO2 ratio depends on both the FiO2 level and the SaO2 level, and that, for changes in FiO2 corresponding to an SaO2 range of 92–98%, 30% of patients change disease classification due to variation in the PaO2/FiO2 ratio. The clinical and scientific utility of the PaO2/FiO2 ratio therefore seems doubtful, and at the very least the FiO2 level at which the PaO2/FiO2 ratio is measured should be specified when quantifying the effects of therapeutic interventions or when specifying diagnostic criteria for ALI and ARDS. Perhaps more appropriate would be to replace the single-parameter PaO2/FiO2 ratio description with two parameters, a parameter to describe the oxygenation problem due to V/Q mismatch and one to describe oxygenation problems due to shunt. Indeed, Riley and Cournand [20] recognized in the 1950s that oxygenation problems should be divided in this way. With the ability to identify two-parameter models rapidly using pulse oximetry data [14] and simple clinical methods [13], their clinical application seems timely. Key messages • The variation in the PaO2/FiO2 ratio with the FiO2 level is scientifically and clinically relevant. • The variation in the PaO2/FiO2 ratio with the FiO2 level cannot be explained with an 'effective shunt' model, and requires a more complex, two-parameter, model. Abbreviations ALI = acute lung injury; ARDS = acute respiratory distress syndrome; ΔPO2 = drop in oxygen pressure from the ventilated alveoli to the mixed blood leaving the lung capillaries oxygen; fA2 = fraction of ventilation to a compartment receiving 90% of nonshunted perfusion; FiO2 = inspired oxygen fraction; PaO2 = partial pressure of oxygen in arterial blood; SaO2 = arterial oxygen saturation; V/Q = ventilation/perfusion. Competing interests SK, SA and SER are all shareholders of Mermaid Care APS, a company involved in the development of equipment for the measurement of pulmonary gas exchange. SA is a board member of Mermaid Care APS. All other authors declare that they have no competing interests. Authors' contributions All authors contributed to the conception and design of the study. SK, KE and CA contributed to the data collection and clinical interpretation of the results. DSK, BWS, SA and SER contributed to the mathematical modelling, data analysis and technical interpretation of the results, including statistical analysis. DSK and SER drafted the manuscript, with all other authors being involved in its revision and approval. Acknowledgements This work was partially supported by the Programme Commission on Nanoscience, Biotechnology and IT under the Danish Council for Strategic Research. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Am J Respir Crit Care Med. 1995 Dec; 152(6 Pt 1):1835-46.
[Am J Respir Crit Care Med. 1995]Crit Care Med. 2007 Jan; 35(1):106-11.
[Crit Care Med. 2007]Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):818-24.
[Am J Respir Crit Care Med. 1994]Am J Respir Crit Care Med. 1998 Apr; 157(4 Pt 1):1332-47.
[Am J Respir Crit Care Med. 1998]Intensive Care Med. 2006 Oct; 32(10):1494-7.
[Intensive Care Med. 2006]Br J Anaesth. 2002 Jun; 88(6):771-8.
[Br J Anaesth. 2002]Crit Care Med. 1997 Jan; 25(1):41-5.
[Crit Care Med. 1997]J Appl Physiol. 1974 May; 36(5):588-99.
[J Appl Physiol. 1974]Intensive Care Med. 2006 Oct; 32(10):1494-7.
[Intensive Care Med. 2006]Crit Care Med. 1999 Nov; 27(11):2445-53.
[Crit Care Med. 1999]Acta Anaesthesiol Scand. 2001 Mar; 45(3):349-56.
[Acta Anaesthesiol Scand. 2001]Anaesthesia. 1997 Jul; 52(7):630-5.
[Anaesthesia. 1997]J Clin Monit Comput. 2002 Jan; 17(1):43-52.
[J Clin Monit Comput. 2002]Intensive Care Med. 2003 May; 29(5):727-34.
[Intensive Care Med. 2003]Acta Anaesthesiol Scand. 2006 Jan; 50(1):64-71.
[Acta Anaesthesiol Scand. 2006]Intensive Care Med. 2006 Oct; 32(10):1494-7.
[Intensive Care Med. 2006]Br J Anaesth. 2002 Jun; 88(6):771-8.
[Br J Anaesth. 2002]Acta Anaesthesiol Scand. 2001 Mar; 45(3):349-56.
[Acta Anaesthesiol Scand. 2001]Intensive Care Med. 2003 May; 29(5):727-34.
[Intensive Care Med. 2003]Eur J Anaesthesiol. 2004 Apr; 21(4):296-301.
[Eur J Anaesthesiol. 2004]J Clin Monit Comput. 2002 Jan; 17(1):43-52.
[J Clin Monit Comput. 2002]Intensive Care Med. 2006 Oct; 32(10):1494-7.
[Intensive Care Med. 2006]Acta Anaesthesiol Scand. 2001 Mar; 45(3):349-56.
[Acta Anaesthesiol Scand. 2001]J Clin Monit Comput. 2002 Jan; 17(1):43-52.
[J Clin Monit Comput. 2002]Intensive Care Med. 2003 May; 29(5):727-34.
[Intensive Care Med. 2003]Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):818-24.
[Am J Respir Crit Care Med. 1994]Am J Respir Crit Care Med. 1998 Apr; 157(4 Pt 1):1332-47.
[Am J Respir Crit Care Med. 1998]Intensive Care Med. 2006 Oct; 32(10):1494-7.
[Intensive Care Med. 2006]Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):818-24.
[Am J Respir Crit Care Med. 1994]J Appl Physiol. 1951 Aug; 4(2):77-101.
[J Appl Physiol. 1951]Intensive Care Med. 2003 May; 29(5):727-34.
[Intensive Care Med. 2003]J Clin Monit Comput. 2002 Jan; 17(1):43-52.
[J Clin Monit Comput. 2002]